Semivisible Higgs boson decay as a probe for new invisible particles
Physical Review D · 30.07.2026 · 114 (1)
DOI: 10.1103/tg5q-n763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review D, online erschienen am 30.07.2026. Verfasst von Sally Dawson und 2 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, U.S. Department of Energy.
Abstract (Originalsprache)
We discuss the HL-LHC sensitivity to probe new invisible particles including scalars and fermions using semivisible Higgs decays in the p p → ZH , Z → j j ( ℓ + ℓ − ) , H → ℓ + ℓ − ( j j ) + E T production mode. The kinematics of these decays allow new particle masses below m ≲ 50 GeV . We carry out our analysis using both a cut-based approach and a multivariate method based on a boosted decision tree. We work within the dark Standard Model effective field theory framework with operators up to dimension six and a discrete Z 2 symmetry under which the new particles are odd and the SM particles are even. We compare our results to those obtained from considering the invisible Z width, as well as perturbative unitarity arguments. Finally, we outline kinematic strategies at the LHC to distinguish different operator structures of the postulated invisible particles.
Förderung
- Australian Research Council
- U.S. Department of Energy
Zitieren
APA
Dawson, S., Roy, A., & Valencia, G. (2026). Semivisible Higgs boson decay as a probe for new invisible particles. Physical Review D, 114(1). https://doi.org/10.1103/tg5q-n763
Vancouver
Dawson S, Roy A, Valencia G. Semivisible Higgs boson decay as a probe for new invisible particles. Physical Review D. 2026;114(1). doi:10.1103/tg5q-n763
BibTeX
@article{Dawson2026,
author = {Dawson, Sally and Roy, Arnab and Valencia, German},
title = {Semivisible Higgs boson decay as a probe for new invisible particles},
journal = {Physical Review D},
year = {2026},
volume = {114},
number = {1},
doi = {10.1103/tg5q-n763}
}
EUVIMED